Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Par, Statin"'
Autor:
Artitaya Lophatananon, José Rubio-Briones, Kenneth Muir, David Thurtle, Ola Bratt, Par Statin, Tristan Barrett, Vincent J. Gnanapragasam, Vineetha Thankapannair, J. Domínguez-Escrig
Publikováno v:
BJU International. 124:758-767
Objectives To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer. Patients and methods We previously developed the Cambridge Prognostics Groups (CPG) classification, a five-tiered
Autor:
Vincent J, Gnanapragasam, Tristan, Barrett, Vineetha, Thankapannair, David, Thurtle, Jose, Rubio-Briones, Jose, Domínguez-Escrig, Ola, Bratt, Par, Statin, Kenneth, Muir, Artitaya, Lophatananon
Publikováno v:
BJU internationalReferences. 124(5)
To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer.We previously developed the Cambridge Prognostics Groups (CPG) classification, a five-tiered model that uses prostate-specifi
Autor:
Gnanapragasam, Vincent J.1,2,3 (AUTHOR) vjg29@cam.ac.uk, Barrett, Tristan4 (AUTHOR), Thankapannair, Vineetha2 (AUTHOR), Thurtle, David1 (AUTHOR), Rubio‐Briones, Jose5 (AUTHOR), Domínguez‐Escrig, Jose5 (AUTHOR), Bratt, Ola6 (AUTHOR), Statin, Par7 (AUTHOR), Muir, Kenneth8 (AUTHOR), Lophatananon, Artitaya8 (AUTHOR)
Publikováno v:
BJU International. Nov2019, Vol. 124 Issue 5, p758-767. 10p.
Publikováno v:
International Journal of Cancer; Nov2002, Vol. 102 Issue 3, p258-261, 4p